Yau Wai-Yin, Chan Man-Chi, Wing Yun-Kwok, Lam Ho-Bun, Lin Wei, Lam Siu-Ping, Lee Chui-Ping
Department of Pharmacy, Prince of Wales Hospital Shatin, Hong Kong.
Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong Shatin, Hong Kong.
Brain Behav. 2014 May;4(3):390-7. doi: 10.1002/brb3.224. Epub 2014 Mar 14.
Noncontinuous antidepressant use is frequently observed in clinical practice despite the standard recommendation of at least 6-9 months of continuous treatment. The problem may be more serious in Chinese populations where stigmatization is common. This retrospective cohort study investigated the rate of noncontinuous antidepressant use and subsequent rate of relapse and recurrence in psychiatric Chinese outpatients by examining the prescription records, electronic medical records, and written medical records. Factors associated with noncontinuous antidepressant use were also identified.
We reviewed the medical records of 189 patients newly dispensed with an antidepressant in the psychiatric outpatient clinic during year 2006 and 2007. Primary outcome was the rate of noncontinuous antidepressant use within 6 months of therapy. Secondary outcomes included the factors associated with noncontinuous antidepressant use and the rate of subsequent depression relapse and recurrence within 1 year of starting treatment.
Among the 189 subjects included in this study, 46% were noncontinuous users of the newly prescribed antidepressant therapy. The noncontinuous users were found to have an eightfold increase (OR: 8.42, 95% CI: 3.30-21.47) in the risks of relapse/recurrence depressive episodes within 1 year after treatment initiation. Younger age (P = 0.008), female, (P = 0.029), residency in public housing estate (P = 0.029), experiencing side effects (P = 0.024), infrequent follow-ups (P = 0.006), and earlier onset of diagnosis (P = 0.034) were factors significantly associated with noncontinuous antidepressant use.
Noncontinuous antidepressant use is common in the local Chinese depressive patients and associated with a high rate of relapse and recurrence. Collaborative multidisciplinary approaches that target patient education and enhancement of follow-up adherence are needed.
尽管标准推荐持续治疗至少6 - 9个月,但在临床实践中经常观察到抗抑郁药的非持续使用情况。在中国人群中,这种问题可能更为严重,因为耻辱感很常见。这项回顾性队列研究通过检查处方记录、电子病历和书面病历,调查了中国精神科门诊患者抗抑郁药非持续使用的发生率以及随后的复发率。还确定了与抗抑郁药非持续使用相关的因素。
我们回顾了2006年和2007年期间在精神科门诊新开具抗抑郁药的189例患者的病历。主要结局是治疗6个月内抗抑郁药非持续使用的发生率。次要结局包括与抗抑郁药非持续使用相关的因素以及开始治疗后1年内随后的抑郁复发率。
在本研究纳入的189名受试者中,46%为新开具抗抑郁药治疗的非持续使用者。发现非持续使用者在治疗开始后1年内复发/复发性抑郁发作的风险增加了八倍(OR:8.42,95% CI:3.30 - 21.47)。年龄较小(P = 0.008)、女性(P = 0.029)、居住在公共屋邨(P = 0.029)、出现副作用(P = 0.024)、随访不频繁(P = 0.006)以及诊断发病较早(P = 0.034)是与抗抑郁药非持续使用显著相关的因素。
抗抑郁药非持续使用在当地中国抑郁症患者中很常见,并且与高复发率相关。需要采取针对患者教育和加强随访依从性的多学科协作方法。